Bayer's Monsanto Seeks Final Approval for $7.25 Billion Roundup Settlement
Bayer AG’s Monsanto unit is set to appear before a Missouri state court on September 14, seeking final approval of its proposed $7.25 billion settlement related to thousands of U.S. lawsuits alleging that the herbicide Roundup causes non-Hodgkin lymphoma. The hearing will be presided over by Judge Timothy Boyer in St. Louis, who is expected to evaluate objections from some plaintiffs' attorneys arguing the deal disadvantages claimants. The proposed agreement aims to resolve both current and future claims against Bayer related to glyphosate exposure. Approximately 65,000 cases are pending across U.S. courts, with individual compensation ranging between $10,000 and $165,000 based on factors like disease severity and age at diagnosis. Critics argue the settlement is financially insufficient and restricts claimants from pursuing trials. The litigation stems from a 2015 World Health Organization classification of glyphosate as a probable carcinogen—contrary to findings by the U.S. Environmental Protection Agency, which maintains it does not cause cancer in humans.
